Mutations in the glucokinase (GCK) gene lead to maturity-onset diabetes of the young, type 2 (MODY-2), and persistent hyperinsulinemic hypoglycemia of infancy (PHHI) [47,49,83]. Here, GCK is linked to congenital isolated hyperinsulinism.